ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - lercanidipine hydrochloride - טבליה - lercanidipine hydrochloride 10 mg - lercanidipine

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - lercanidipine hydrochloride - טבליה - lercanidipine hydrochloride 20 mg - lercanidipine

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - tofacitinib as citrate - טבליות עם שחרור נרחב - tofacitinib as citrate 11 mg - tofacitinib

ישראל - עברית - Ministry of Health

padagis israel pharmaceuticals ltd, israel - lactulose - סירופ - lactulose 66.7 g / 100 ml - lactulose - lactulose - constipation. acute and chronic hepatic encephalopathy.

ישראל - עברית - Ministry of Health

neopharm consumer products ltd, israel - polyethylene glycol 3350 - אבקה להכנת תרחיף - polyethylene glycol 3350 99.973 %w/w - macrogol - macrogol - treatment of constipation.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - propafenone hydrochloride - טבליה - propafenone hydrochloride 300 mg - propafenone - propafenone - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.

ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - propafenone hydrochloride - טבליה - propafenone hydrochloride 150 mg - propafenone - propafenone - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - diltiazem hydrochloride - טבליה - diltiazem hydrochloride 60 mg - diltiazem - diltiazem - calcium channel blocker for the treatment of angina pectoris.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - cilazapril - טבליה - cilazapril 2.5 mg - cilazapril - cilazapril - treatment of essential hypertension, renal hypertension and chronic heart failure.